Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
Claude Sportès, Frances T. Hakim, Sarfraz Memon, et al.
The Journal of Experimental Medicine (2008) Vol. 205, Iss. 7, pp. 1701-1714
Open Access | Times Cited: 459

Showing 1-25 of 459 citing articles:

Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells
Harlan Robins, Paulo Vidal Campregher, Santosh K. Srivastava, et al.
Blood (2009) Vol. 114, Iss. 19, pp. 4099-4107
Open Access | Times Cited: 1081
New insights into the regulation of T cells by γc family cytokines
Yrina Rochman, Rosanne Spolski, Warren J. Leonard
Nature reviews. Immunology (2009) Vol. 9, Iss. 7, pp. 480-490
Open Access | Times Cited: 961
The Basis of Oncoimmunology
Karolina Palucka, Lisa M. Coussens
Cell (2016) Vol. 164, Iss. 6, pp. 1233-1247
Open Access | Times Cited: 738
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux, Thomas Henry, Alexandre Bélot, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102567-102567
Open Access | Times Cited: 653
Harnessing the biology of IL-7 for therapeutic application
Crystal L. Mackall, Terry J. Fry, Ronald E. Gress
Nature reviews. Immunology (2011) Vol. 11, Iss. 5, pp. 330-342
Open Access | Times Cited: 518
Immune cell dysfunction and inflammation in end-stage renal disease
Michiel G.H. Betjes
Nature Reviews Nephrology (2013) Vol. 9, Iss. 5, pp. 255-265
Closed Access | Times Cited: 484
Design and development of therapies using chimeric antigen receptor‐expressing T cells
Gianpietro Dotti, Stephen Gottschalk, Barbara Savoldo, et al.
Immunological Reviews (2013) Vol. 257, Iss. 1, pp. 107-126
Open Access | Times Cited: 471
Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
Ken‐ichi Matsuoka, John Koreth, Haesook T. Kim, et al.
Science Translational Medicine (2013) Vol. 5, Iss. 179
Open Access | Times Cited: 436
Hallmarks of T cell aging
Marı́a Mittelbrunn, Guido Kroemer
Nature Immunology (2021) Vol. 22, Iss. 6, pp. 687-698
Closed Access | Times Cited: 384
Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment
Yves Lévy, Christine Lacabaratz, Laurence Weiss, et al.
Journal of Clinical Investigation (2009)
Open Access | Times Cited: 360
Naive T cell homeostasis: from awareness of space to a sense of place
Kensuke Takada, Stephen C. Jameson
Nature reviews. Immunology (2009) Vol. 9, Iss. 12, pp. 823-832
Closed Access | Times Cited: 354
IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection
Irini Sereti, Richard M. Dunham, John Spritzler, et al.
Blood (2009) Vol. 113, Iss. 25, pp. 6304-6314
Open Access | Times Cited: 329
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Bruno François, Robin Jeannet, Thomas Daix, et al.
JCI Insight (2018) Vol. 3, Iss. 5
Open Access | Times Cited: 325
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
Bipulendu Jena, Gianpietro Dotti, Laurence J.N. Cooper
Blood (2010) Vol. 116, Iss. 7, pp. 1035-1044
Open Access | Times Cited: 297
IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
Marc Pellegrini, Thomas Calzascia, Jesse G. Toe, et al.
Cell (2011) Vol. 144, Iss. 4, pp. 601-613
Open Access | Times Cited: 293
Current trends in inflammatory and immunomodulatory mediators in sepsis
Monowar Aziz, Asha Jacob, Weng-Lang Yang, et al.
Journal of Leukocyte Biology (2012) Vol. 93, Iss. 3, pp. 329-342
Open Access | Times Cited: 292
IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis
Jacqueline Unsinger, Margaret McGlynn, Kevin R. Kasten, et al.
The Journal of Immunology (2010) Vol. 184, Iss. 7, pp. 3768-3779
Open Access | Times Cited: 288
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
Mayte Coiras, María Rosa López‐Huertas, Mayte Pérez‐Olmeda, et al.
Nature Reviews Microbiology (2009) Vol. 7, Iss. 11, pp. 798-812
Closed Access | Times Cited: 284
Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections
Ming Zeng, Anthony J. Smith, Stephen W. Wietgrefe, et al.
Journal of Clinical Investigation (2011) Vol. 121, Iss. 3, pp. 998-1008
Open Access | Times Cited: 284
Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update
Ruth Seggewiss, Hermann Einsele
Blood (2010) Vol. 115, Iss. 19, pp. 3861-3868
Closed Access | Times Cited: 281
Flip the coin: IL-7 and IL-7R in health and disease
João T. Barata, Scott K. Durum, Benedict Seddon
Nature Immunology (2019) Vol. 20, Iss. 12, pp. 1584-1593
Open Access | Times Cited: 277
Therapeutic Cancer Vaccines: Current Status and Moving Forward
J Schlom
JNCI Journal of the National Cancer Institute (2012) Vol. 104, Iss. 8, pp. 599-613
Open Access | Times Cited: 272
The changing immune system in sepsis
Jonathan Boomer, Jonathan M. Green, Richard S. Hotchkiss
Virulence (2013) Vol. 5, Iss. 1, pp. 45-56
Open Access | Times Cited: 270
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Christine Ménétrier‐Caux, Isabelle Ray‐Coquard, Jean‐Yves Blay, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 256
Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study
Yves Lévy, Irini Sereti, Giuseppe Tambussi, et al.
Clinical Infectious Diseases (2012) Vol. 55, Iss. 2, pp. 291-300
Open Access | Times Cited: 219
Page 1 - Next Page

Scroll to top